Trilink biotechnologies® partners with avantor® to expand nucleic acid solutions in europe

San diego--(business wire)--trilink biotechnologies (trilink®), a maravai® lifesciences company (nasdaq: mrvi) and global provider of life science reagents and services, has partnered with, avantor, inc. (nyse: avtr), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, to expand availability of its innovative nucleic acid products to customers across europe, middle east, and africa (emea). this distribution pa.
AVTR Ratings Summary
AVTR Quant Ranking